Endocrine Metabolic Syndrome and Metabolic Syndrome: Distinct but Interrelated Pathologies
Gynecologic and Obstetric Investigation · 20.03.2025 · 90 (6) · 576-586
DOI: 10.1159/000545280 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Gynecologic and Obstetric Investigation, online erschienen am 20.03.2025. Verfasst von Vittorio Unfer und 3 weiteren Autor:innen. Beteiligte Einrichtung: R&D Department, Lo.Li Pharma, Rome, Italy. Hauptthemen laut MEDLINE: Metabolic Syndrome, Polycystic Ovary Syndrome. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 78 Literaturangaben.
Abstract (Originalsprache)
Background
Polycystic ovary syndrome, or endocrine metabolic syndrome (EMS) as recently proposed by the Expert Group on Inositol in basic and clinical research and on PCOS (EGOI-PCOS), manifests as a series of metabolic and hormonal alterations, which are primarily suspected to be underpinned by an underlying metabolic problem. Several of these metabolic issues are shared with metabolic syndrome (MetS), a separate but interrelated metabolic disorder typified by obesity, heightened glucose levels, dyslipidemia, and cardiovascular risk factors.
Objectives
This review sets out to expand upon the interplay between EMS and MetS, defining the key characteristics of each condition prior to discussing treatment options that may benefit both sets of patients.
Methods
A narrative review of all the relevant papers in English language was conducted. Outcome: Both EMS and MetS share common features, such as obesity, dyslipidemia, and cardiovascular risk factors, and thus can be treated in certain circumstances with similar therapeutic approaches. However, in both women and men, does not feature alterations of androgen levels, as is the case with EMS. Furthermore, these conditions tend to occur in different age groups, with MetS primarily occurring during or after menopause, while EMS occurs in women of reproductive age. Conclusions and Outlook: These two conditions share considerable overlap, and one may trigger the other in affected patients; however, the causality is currently unclear and requires further study.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- R&D Department, Lo.Li Pharma, Rome, Italy.
- CarMeN Laboratory, INSERM U1060, INRAe U1397, Université Claude Bernard Lyon 1, Bron, France.
- The Experts Group on Inositol in Basic and Clinical Research and on PCOS (EGOI-PCOS), Rome, Italy.
- UniCamillus-Saint Camillus International University of Health Sciences, Rome, Italy.
Zitieren
APA
Unfer, V., Myers, S. H., Soulage, C. O., & Unfer, V. (2025). Endocrine Metabolic Syndrome and Metabolic Syndrome: Distinct but Interrelated Pathologies. Gynecologic and Obstetric Investigation, 90(6), 576-586. https://doi.org/10.1159/000545280
Vancouver
Unfer V, Myers SH, Soulage CO, Unfer V. Endocrine Metabolic Syndrome and Metabolic Syndrome: Distinct but Interrelated Pathologies. Gynecologic and Obstetric Investigation. 2025;90(6):576-586. doi:10.1159/000545280
BibTeX
@article{Unfer2025,
author = {Unfer, Vittorio and Myers, Samuel H and Soulage, Christophe O and Unfer, Vittorio},
title = {Endocrine Metabolic Syndrome and Metabolic Syndrome: Distinct but Interrelated Pathologies},
journal = {Gynecologic and Obstetric Investigation},
year = {2025},
volume = {90},
number = {6},
pages = {576--586},
doi = {10.1159/000545280}
}
EUVIMED